@CNN: The FDA is re-examining the safety of a medication that was approved despite concerns that not enough was known about the drug’s risks https://t.co/PKEESfgWuQ
The FDA is re-examining the safety of a medication that was approved despite concerns that not enough was known about the drug's risks https://t.co/PKEESfgWuQ
— CNN (@CNN) April 25, 2018